These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11817524)

  • 1. Monitoring high-dose heparin levels by ACT and HMT during extracorporeal circulation: diagnostic accuracy of three compact monitors.
    Giavarina D; Carta M; Fabbri A; Manfredi J; Gasparotto E; Soffiati G
    Perfusion; 2002 Jan; 17(1):23-6. PubMed ID: 11817524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test.
    Wallock M; Jeske WP; Bakhos M; Walenga JM
    Perfusion; 2001 Mar; 16(2):147-53. PubMed ID: 11334198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.
    Chia S; Van Cott EM; Raffel OC; Jang IK
    Thromb Haemost; 2009 Mar; 101(3):535-40. PubMed ID: 19277416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).
    Tremey B; Szekely B; Schlumberger S; François D; Liu N; Sievert K; Fischler M
    Br J Anaesth; 2006 Oct; 97(4):453-9. PubMed ID: 16873382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does the age of a blood sample affect it's activated clotting time? Comparison of eight different devices.
    Searles B; Nasrallah F; Darling E; Yarcusko S
    J Extra Corpor Technol; 2002 Sep; 34(3):175-7. PubMed ID: 12395961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.
    Schroeder AP; Knudsen LL; Husted SE; Knudsen L; Ingerslev J
    J Thromb Thrombolysis; 2001 Oct; 12(2):157-63. PubMed ID: 11729367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the heparin management test and the HemoTec activated clotting time in patients undergoing percutaneous coronary intervention.
    Tsimikas S; Beyer R; Hassankhani A
    J Thromb Thrombolysis; 2001 May; 11(3):217-21. PubMed ID: 11577260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.
    Dirkmann D; Nagy E; Britten MW; Peters J
    BMC Anesthesiol; 2019 Sep; 19(1):174. PubMed ID: 31492108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin monitoring during cardiac surgery. Part 1: Validation of whole-blood heparin concentration and activated clotting time.
    Raymond PD; Ray MJ; Callen SN; Marsh NA
    Perfusion; 2003 Sep; 18(5):269-76. PubMed ID: 14604242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin management test versus activated coagulation time during cardiovascular surgery: correlation with anti-Xa activity.
    Fitch JC; Geary KL; Mirto GP; Byrne DW; Hines RL
    J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):53-7. PubMed ID: 10069285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic accuracy of bedside and laboratory coagulation: procedures used to monitor the anticoagulation status of patients treated with heparin.
    Solomon HM; Mullins RE; Lyden P; Thompson P; Hudoff S
    Am J Clin Pathol; 1998 Apr; 109(4):371-8. PubMed ID: 9535388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a bedside activated clotting time test (Hemochron Jr II Signature) with low dose heparin therapy.
    Racioppi L; Quinart A; Biais M; Nouette-Gaulain K; Revel P; Sztark F
    Anaesthesia; 2009 Apr; 64(4):430-4. PubMed ID: 19317710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of heparin administration using the Rapidpoint Coag and Hepcon HMS.
    Newsome J; Stipanovich K; Flaherty S
    J Extra Corpor Technol; 2004 Jun; 36(2):139-44. PubMed ID: 15334753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative Monitoring of Heparin: Comparison of Activated Coagulation Time and Whole Blood Heparin Measurements by Different Point-of-Care Devices with Heparin Concentration by Laboratory-Performed Plasma Anti-Xa Assay.
    Thompson TZ; Kunak RL; Savage NM; Agarwal S; Chazelle J; Singh G
    Lab Med; 2019 Oct; 50(4):348-356. PubMed ID: 31053856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heparin management test: a new device for monitoring anticoagulation during coronary intervention.
    Helft G; Bartolomeo P; Zaman AG; Worthley SG; Chokron S; Le Pailleur C; Beygui F; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
    Thromb Res; 1999 Dec; 96(6):481-5. PubMed ID: 10632472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test.
    Silvain J; Beygui F; Ankri A; Bellemain-Appaix A; Pena A; Barthelemy O; Cayla G; Gallois V; Galier S; Costagliola D; Collet JP; Montalescot G
    J Am Coll Cardiol; 2010 Feb; 55(7):617-25. PubMed ID: 20170785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
    Paniccia R; Fedi S; Carbonetto F; Noferi D; Conti P; Bandinelli B; Giusti B; Evangelisti L; Pretelli P; Palmarini MF; Abbate R; Prisco D
    Anesthesiology; 2003 Jul; 99(1):54-9. PubMed ID: 12826842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin monitoring during cardiac surgery. Part 2: Calculating the overestimation of heparin by the activated clotting time.
    Raymond PD; Ray MJ; Callen SN; Marsh NA
    Perfusion; 2003 Sep; 18(5):277-81. PubMed ID: 14604243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifactor Xa Activity for the Management of Anticoagulation during Cardiac Surgery.
    Reyher C; Würfel C; Lindhoff-Last E; Meybohm P; Zacharowski K; Moritz A; Schindewolf M; Weber CF
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):494-500. PubMed ID: 26757210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.